HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jinsil Seong Selected Research

Messenger RNA (mRNA)

7/2019Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma.
7/2019Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jinsil Seong Research Topics

Disease

119Hepatocellular Carcinoma (Hepatoma)
03/2024 - 09/2002
85Neoplasms (Cancer)
01/2024 - 09/2002
30Neoplasm Metastasis (Metastasis)
02/2024 - 09/2002
14Liver Neoplasms (Liver Cancer)
05/2021 - 03/2007
13Pancreatic Neoplasms (Pancreatic Cancer)
05/2024 - 01/2009
11Thrombosis (Thrombus)
06/2023 - 09/2008
7Rectal Neoplasms (Rectal Cancer)
06/2012 - 02/2006
5Lymphopenia (Lymphocytopenia)
05/2024 - 11/2019
5Liver Diseases (Liver Disease)
01/2020 - 09/2006
4Cholangiocarcinoma
01/2024 - 03/2014
4Adenocarcinoma
08/2023 - 11/2004
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2010 - 09/2002
3Pain (Aches)
03/2019 - 12/2004
3Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2016 - 01/2014
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2008 - 11/2004
2Carcinoma (Carcinomatosis)
12/2021 - 09/2003
2Hemorrhage
08/2021 - 09/2013
2Stomach Neoplasms (Stomach Cancer)
08/2021 - 03/2013
2Residual Neoplasm
07/2019 - 07/2019
2Duodenal Ulcer (Curling's Ulcer)
06/2019 - 01/2016
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2019 - 12/2011
2Lymphatic Metastasis
11/2017 - 02/2011
2Disease Progression
02/2012 - 09/2006
2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2007 - 01/2007
1Compression Fractures (Compression Fracture)
07/2023
1Gallbladder Neoplasms (Gallbladder Cancer)
06/2022
1Radiation Pneumonitis
05/2022
1Margins of Excision
12/2021
1Hypoalbuminemia
10/2021
1Leukopenia
10/2021
1Klatskin Tumor
08/2021
1Diarrhea
01/2020

Drug/Important Bio-Agent (IBA)

14Sorafenib (BAY 43-9006)FDA Link
06/2023 - 01/2011
10Fluorouracil (Carac)FDA LinkGeneric
09/2016 - 09/2003
6Cisplatin (Platino)FDA LinkGeneric
01/2024 - 11/2007
6GemcitabineFDA Link
01/2024 - 01/2009
6Proteins (Proteins, Gene)FDA Link
06/2022 - 04/2005
6Biomarkers (Surrogate Marker)IBA
06/2022 - 01/2009
5CytokinesIBA
10/2021 - 01/2014
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2020 - 01/2012
3CarbohydratesIBA
01/2024 - 03/2009
3Interleukin-6 (Interleukin 6)IBA
04/2016 - 03/2006
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2016 - 11/2004
3Interleukin-12 (IL 12)IBA
01/2016 - 01/2011
3Thioacetamide (Thioacetamid)IBA
01/2010 - 09/2003
2CarbonIBA
05/2024 - 10/2023
2AntigensIBA
01/2024 - 03/2009
2Interleukin-7 (Interleukin 7)IBA
10/2021 - 01/2021
2Immunoglobulins (Immunoglobulin)IBA
05/2021 - 07/2012
2Immune Checkpoint InhibitorsIBA
03/2021 - 06/2017
2Tumor Biomarkers (Tumor Markers)IBA
11/2020 - 01/2019
2Alkaline PhosphataseIBA
01/2020 - 09/2006
2Therapeutic UsesIBA
12/2019 - 06/2017
2Histones (Histone)IBA
07/2019 - 07/2019
2Messenger RNA (mRNA)IBA
07/2019 - 07/2019
2Complement System Proteins (Complement)IBA
06/2017 - 12/2005
2Transforming Growth Factor beta1 (TGF beta 1)IBA
04/2016 - 01/2014
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 01/2014
2InterleukinsIBA
01/2016 - 08/2015
2acarboxyprothrombin (PIVKA)IBA
02/2014 - 01/2012
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
08/2012 - 09/2003
2Leucovorin (Folinic Acid)FDA Link
02/2011 - 11/2008
2Carcinoembryonic AntigenIBA
03/2010 - 02/2006
2Substance PIBA
04/2005 - 12/2004
2Calcitonin Gene-Related PeptideIBA
04/2005 - 12/2004
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
01/2024
1IonsIBA
10/2023
1N-acetyltalosaminuronic acid (NAT)IBA
08/2023
1Bevacizumab (Avastin)FDA Link
03/2023
1atezolizumabIBA
03/2023
1Vitamin KFDA Link
06/2022
1antineoplaston A10 (A 10)IBA
01/2022
1Fetal Proteins (Fetoprotein)IBA
09/2021
1MucinsIBA
05/2021
1Thomsen-Friedenreich antibodiesIBA
05/2021

Therapy/Procedure

123Radiotherapy
03/2024 - 09/2002
32Chemoradiotherapy
05/2022 - 06/2006
28Therapeutics
05/2024 - 09/2008
21Drug Therapy (Chemotherapy)
01/2024 - 09/2003
11Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2019 - 06/2008
7Conformal Radiotherapy
10/2019 - 09/2002
6Radiofrequency Ablation
01/2023 - 01/2018
5Adjuvant Radiotherapy
06/2022 - 01/2008
4Liver Transplantation
02/2024 - 01/2013
4Re-Irradiation
10/2023 - 06/2012
4Neoadjuvant Therapy
08/2023 - 04/2009
3Transplantation
02/2024 - 04/2005
3Immunotherapy
03/2023 - 06/2017
3Aftercare (After-Treatment)
10/2016 - 02/2009
2Heavy Ion Radiotherapy
05/2024 - 10/2023
2Palliative Care (Palliative Therapy)
09/2021 - 01/2010
2Pancreatectomy
12/2015 - 09/2014
2Surgical Instruments (Clip)
10/2014 - 03/2007
2Brachytherapy
11/2007 - 09/2003
1Adjuvant Chemoradiotherapy
12/2021
1Combined Modality Therapy
09/2021
1Contraindications
09/2021
1Blood Transfusion (Blood Transfusions)
08/2021
1Conservative Treatment
01/2020
1Stents
09/2019